New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2013
10:25 EDTINFI, INFISummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Infinity Pharmaceutical's (INFI) IPI-145 and whether it is safe as a non-cancer agent and if it will be effective as an asthma treatment on an Analyst/Industry conference call to be held on December 12 at 11 am.
News For INFI From The Last 14 Days
Check below for free stories on INFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
17:25 EDTINFIPoint72 Asset lowers passive stake in Infinity Pharmaceuticals to 7.1% from 7.5%
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use